BaileyJr., Donald B.
January 2009
Health Matrix: Journal of Law-Medicine;Winter2009, Vol. 19 Issue 1, p141
Academic Journal
The article cites the important difference between treatable and untreatable condition for a newborn screening in the U.S. It discusses the specific definition of each treatment, including concepts of benefits and evidence standards before undergoing to a screening program. It mentions that the program was typically designed to reduce the mortality rate in the country.


Related Articles

  • SCREENING NEWBORNS: Just the Beginning. Johnson, Alissa // State Legislatures;Apr2008, Vol. 34 Issue 4, p20 

    The article provides information on newborn screening in the U.S. In 2005, the American College of Medical Genetics released a report recommending screens for 29 core conditions and identifying 25 other conditions that could be detected in the same screening. According the National Newborn...

  • SYSTEMS TO DETERMINE TREATMENT EFFECTIVENESS IN NEWBORN SCREENING. Howell, R. Rodney // Health Matrix: Journal of Law-Medicine;Winter2009, Vol. 19 Issue 1, p155 

    The article focuses on the medical system and techniques applied in a newborn screening presented by physician Rodney Howell during the medical screening workshop in the U.S. on May 2, 2008. Howell discussed the value and importance of a medical system to determine the specific treatment for a...

  • ASSESSING THE NEW CRITERIA FOR NEWBORN SCREENING. Botkin, Jeffrey R. // Health Matrix: Journal of Law-Medicine;Winter2009, Vol. 19 Issue 1, p163 

    The article focuses on the criteria of a newborn screening program presented by physician Jeffrey R. Botkin during his lecture at a medical screening workshop in the U.S. on May 2, 2008. Botkin cited that the program must have an accurate screening test, efficient outreach and engagement effort,...

  • ON TREATABILITY: CONSIDERATIONS OF TREATMENT IN THE CONTEXT OF NEWBORN SCREENING. Natowicz, Marvin R.; Zuckerman, Shiomit // Health Matrix: Journal of Law-Medicine;Winter2009, Vol. 19 Issue 1, p187 

    The article cites the important aspect of treatability in a newborn screening program presented by physicians Marvin R. Natowicz and Shlomit Zuckerman during their lecture at a medical screening workshop in the U.S. on May 2, 2008. Natowicz and Zuckerman argued that the program have various...

  • Clinical Utility Gene Card for: 3-M syndrome - Update 2013. Holder-Espinasse, Muriel; Irving, Melita; Cormier-Daire, ValĂ©rie // European Journal of Human Genetics;Apr2014, Vol. 22 Issue 4, p00 

    The article presents the update of the clinical utility gene card for 3-M syndrome in 2013. Topics include the characteristics of the disease, its test characteristics, and clinical utility of 3-M syndrome. Also mentioned are the differential diagnosis of the Russel-Silver syndrome (RSS) and the...

  • Tests.  // MLO: Medical Laboratory Observer;Jul2007, Vol. 39 Issue 7, p68 

    The article offers news briefs related to medical tests. The MammaPrint breast-cancer test is considered as the first molecular test used to profile genetic activity. This test uses molecular technology in studying patterns of behavior of large number of genes in biological samples. The Xpert EV...

  • Clinicians are beginning to use genetic information in patient management. Bechtel, Bryan // Primary Care Optometry News;Jun2009, Vol. 14 Issue 6, p16 

    This article deals with the growing use of genetic information in clinical practice in testing and counseling.

  • Analysing the Output from Primary Screening. Nowlin, Dawn; Bingham, Patrick; Berridge, Andrew; Gribbon, Philip; Laflin, Philip; Sewing, Andreas // Combinatorial Chemistry & High Throughput Screening;Jun2006, Vol. 9 Issue 5, p331 

    From a perspective of process knowledge and enhancement, the analysis of the results of biological screening should not be limited to the outcome of specific projects, but additionally encompass a process centric view. Summarising outcomes across multiple projects is a powerful tool to gain a...

  • U.S. newborn screening expands. Rottman, Erin // Fit Pregnancy;Jun/Jul2009, Vol. 15 Issue 9, p58 

    The article reports that state-mandated screening for 21 or more rare genetic and metabolic disorders are done in the U.S. for nearly all newborns. It is stated that many of the disorders if found early can be treated effectively.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics